港股异动 | 金斯瑞生物科技(01548)涨超3% CARVYKTI®第三季度产生贸易销售净额约5.24亿美元

Core Viewpoint - Kingsray Biotechnology (01548) has seen a stock price increase of over 3%, currently trading at 16.27 HKD with a transaction volume of 32.066 million HKD, following the announcement of projected trade sales from its collaboration with Janssen Biotech, Inc. [1] Group 1 - Kingsray Biotechnology announced that CARVYKTI is expected to generate trade sales net revenue of approximately 524 million USD for the quarter ending September 30, 2025, as per the collaboration and licensing agreement established with Janssen on December 21, 2017 [1]